Delivery Order SPE2DB20D3103-SPE2DB25FN1J9
Award Date
3/20/25
Potential Completion Date
3/21/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,176.35, is for the delivery of bupropion hydrochloride extended-release tablets in quantities of 500 per bottle. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the period of performance runs through January 17, 2024. This award is part of a larger Indefinite...
This contract award is for the delivery of bupropion hydrochloride extended-release tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $41,468.18 and a period of performance through March 19, 2024. It does not have...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,082.02, is for the provision of bupropion hydrochloride extended-release tablets (300 mg, 90-count). The contract has a period of performance through May 8, 2024 and does not have a set-aside designation, indicating it was competitively awarded....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,703.32 firm fixed price delivery order contract is for the supply of bupropion hydrochloride extended-release 150 mg tablets in 500-count bottles. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Bupropion HCL XL 150 mg tablets and has a ceiling value of $4,197.15. It is a firm fixed-price delivery order contract with an ultimate completion date of August 8, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,867,821 units of Bupropion HCL XL 300 mg tablets in 500-count bottles, with a ceiling value of $14,307.61. The contract has a firm fixed price and an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of bupropion hydrochloride extended-release (XL) 150 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,173.96 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, with a performance period through March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BUPROPION HCL XL 300 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $105,516.75 and a performance period ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Bupropion HCL XL 300 mg tablets. The contract has a fixed-price, firm-fixed-price structure and a ceiling value of $56,117.46. The ultimate completion date is May 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...